Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-02-09

FDA Approved: BEPOTASTINE BESILATE — Supplemental Application (Bausch & Lomb Americas Inc.)

View source ↗

Summary

FDA approved a supplemental application for BEPOTASTINE BESILATE from Bausch & Lomb Americas Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bepotastine besilate (Bepotastine besilate)

Snippet

SUPPL AP for BEPOTASTINE BESILATE (BEPOTASTINE BESILATE)